Prudential PLC
5 May 2000
BOARD CHANGES AT PRUDENTIAL
Prudential plc announced today the appointment of Sir Roger Hurn as Chairman
with immediate effect. He succeeds Sir Martin Jacomb, who retired as Chairman
and as a director at the conclusion of the Company's AGM today.
Sir Roger, Chairman of Marconi and Deputy Chairman of Glaxo Wellcome, has been
a non-executive director at Prudential since February 2000.
Michael Abrahams has also retired as Deputy Chairman and as a director at the
conclusion of the Company's AGM today.
Enquiries:
Jeremy Reynolds/Tina Christou
Prudential Media Relations
Tel: 020 7548 3721/3719
NOTE TO EDITORS
Sir Roger Hurn (61) Chairman of Marconi, and Deputy Chairman of Glaxo Wellcome
(since 1997) and a non-executive of ICI (since 1993)
Prior to this he spent forty years with Smith's Industries. He became Chief
Executive in 1981 and Chairman from 1991-98. He joined Smiths Industries
after a two-year engineering apprenticeship at Rolls Royce Motors and spent
his early career in the company's international activities.
Sir Roger is also Chairman of the Court of Governors of The Henley Management
College. In 1996 he was knighted for services to the engineering industry.
Sir Martin Jacomb has been a director of Prudential since 1994 and was elected
Chairman in 1995.
Michael Abrahams has been a director of Prudential since 1984 and Deputy
Chairman since 1991.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.